|
1
|
Miyata H, Yamasaki M, Kurokawa Y, et al:
Survival factors in patients with recurrence after curative
resection of esophageal squamous cell carcinomas. Ann Surg Oncol.
18:3353–3361. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Toh Y, Oki E, Minami K and Okamura T:
Follow-up and recurrence after a curative esophagectomy for
patients with esophageal cancer: the first indicators for
recurrence and their prognostic values. Esophagus. 7:37–43. 2010.
View Article : Google Scholar
|
|
3
|
Kunisaki C, Makino H, Takagawa R, et al:
Surgical outcomes in esophageal cancer patients with tumor
recurrence after curative esophagectomy. J Gastrointest Surg.
12:802–810. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nakagawa S, Kanda T, Kosugi S, Ohashi M,
Suzuki T and Hatakeyama K: Recurrence pattern of squamous cell
carcinoma of the thoracic esophagus after extended radical
esophagectomy with three-field lymphadenectomy. J Am Coll Surg.
198:205–211. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shimada H, Kitabayashi H, Nabeya Y, et al:
Treatment response and prognosis of patients after recurrence of
esophageal cancer. Surgery. 133:24–31. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Worni M, Martin J, Gloor B, et al: Does
surgery improve outcomes for esophageal squamous cell carcinoma? An
analysis using the surveillance epidemiology and end results
registry from 1998 to 2008. J Am Coll Surg. 215:643–651. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bosset JF, Gignoux M, Triboulet JP, et al:
Chemoradiotherapy followed by surgery compared with surgery alone
in squamous-cell cancer of the esophagus. N Engl J Med.
337:161–167. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee JL, Park SI, Kim SB, et al: A single
institutional phase III trial of preoperative chemotherapy with
hyperfractionation radiotherapy plus surgery versus surgery alone
for resectable esophageal squamous cell carcinoma. Ann Oncol.
15:947–954. 2004. View Article : Google Scholar
|
|
9
|
Leveson SH, Wiggins PA, Giles GR, Parkin A
and Robinson PJ: Deranged liver blood flow patterns in the
detection of liver metastases. Br J Surg. 72:128–130. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Leen E, Goldberg JA, Robertson J,
Sutherland GR and McArdle CS: The use of duplex sonography in the
detection of colorectal hepatic metastases. Br J Cancer.
63:323–325. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Carter R, Anderson JH, Cooke TG, Baxter JN
and Angerson WJ: Splanchnic blood flow changes in the presence of
hepatic tumour: evidence of a humoral mediator. Br J Cancer.
69:1025–1026. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nott DM, Grime SJ, Yates J, et al: Changes
in the hepatic perfusion index during the development of
experimental hepatic tumours. Br J Surg. 76:259–263. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cuenod C, Leconte I, Siauve N, et al:
Early changes in liver perfusion caused by occult metastases in
rats: detection with quantitative CT. Radiology. 218:556–561. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Leggett DA, Kelley BB, Bunce IH and Miles
KA: Colorectal cancer: diagnostic potential of CT measurements of
hepatic perfusion and implications for contrast enhancement
protocols. Radiology. 205:716–720. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Miles KA, Hayball M and Dixon AK: Colour
perfusion imaging: a new application of computed tomography.
Lancet. 337:643–645. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ronot M, Asselah T, Paradis V, et al:
Liver fibrosis in chronic hepatitis C virus infection:
differentiating minimal from intermediate fibrosis with perfusion
CT. Radiology. 256:135–142. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hashimoto K, Murakami T, Dono K, et al:
Assessment of the severity of liver disease and fibrotic change:
The usefulness of hepatic CT perfusion imaging. Oncol Rep.
16:677–683. 2006.PubMed/NCBI
|
|
18
|
Pandharipande PV, Krinsky GA, Rusinek H
and Lee VS: Perfusion imaging of the liver: current challenges and
future goals. Radiology. 234:661–673. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Van Beers BE, Leconte I, Materne R, Smith
AM, Jamart J and Horsmans Y: Hepatic perfusion parameters in
chronic liver disease: dynamic CT measurement correlated with
disease severity. AJR Am J Roentgenol. 176:667–673. 2001.PubMed/NCBI
|
|
20
|
Tsushima Y, Funabasama S, Aoki J, Sanada S
and Endo K: Quantitative perfusion map of malignant liver tumors,
created from dynamic computed tomography data. Acad Radiol.
11:215–223. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sahani DV, Holalhere NS, Mueller PR and
Zhu AX: Advanced hepatocellular carcinoma: CT perfusion of liver
and tumor tissue - initial experience. Radiology. 243:736–743.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Satoh A, Shuto K, Okazumi S, et al: Role
of perfusion CT in assessing tumor blood flow and malignancy level
of gastric cancer. Dig Surg. 27:253–260. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Miles KA, Leggett DA, Kelley BB, Hayball
MP, Sinnatamby R and Bunce I: In vivo assessment of
neovascularization of liver metastases using perfusion CT. Br J
Radiol. 71:276–281. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Morsbach F, Pfammatter T, Reiner CS, et
al: Computed tomographic perfusion imaging for the prediction of
response and survival to transarterial radioembolization of liver
metastases. Invest Radiol. 48:787–794. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hayano K, Okazumi S, Shuto K, et al:
Perfusion CT can predict the response to chemoradiation therapy and
survival in esophageal squamous cell carcinoma: Initial clinical
results. Oncol Rep. 18:901–908. 2007.PubMed/NCBI
|
|
26
|
Hayano K, Shuto K, Koda K, Yanagawa N,
Okazumi S and Matsubara H: Quantitative measurement of blood flow
using perfusion CT for assessing clinicopathologic features and
prognosis in patients with rectal cancer. Dis Colon Rectum.
52:1624–1629. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Ando N, Kato H, Igaki H, et al: A
randomized trial comparing postoperative adjuvant chemotherapy with
cisplatin and 5-fluorouracil versus preoperative chemotherapy for
localized advanced squamous cell carcinoma of the thoracic
esophagus (JCOG9907). Ann Surg Oncol. 19:68–74. 2012. View Article : Google Scholar
|
|
28
|
Miles KA, Hayball M and Dixon AK:
Functional images of hepatic perfusion obtained with dynamic CT.
Radiology. 188:405–411. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang X, Xue HD, Jin ZY, et al:
Quantitative hepatic CT perfusion measurement: comparison of
Couinaud’s hepatic segments with dual-source 128-slice CT. Eur J
Radiol. 82:220–226. 2013.
|
|
30
|
Ng CS, Chandler AG, Wei W, et al:
Reproducibility of CT perfusion parameters in liver tumors and
normal liver. Radiology. 260:762–770. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huguier M, Maheswari S, Toussaint P, Houry
S, Mauban S and Mensch B: Hepatic flow scintigraphy in evaluation
of hepatic metastases in patients with gastrointestinal malignancy.
Arch Surg. 128:1057–1059. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Warren HW, Gallagher H, Hemingway DM, et
al: Prospective assessment of the hepatic perfusion index in
patients with colorectal cancer. Br J Surg. 85:1708–1712. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Leen E, Goldberg JA, Angerson WJ and
McArdle CS: Potential role of doppler perfusion index in selection
of patients with colorectal cancer for adjuvant chemocherapy.
Lancet. 355:34–37. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hemingway DM, Cooke TG, Grime SJ, Nott DM
and Lenkins SA: Changes in hepatic haemodynamics and hepatic
perfusion index during the growth and development of hypovascular
HSN sarcoma in rats. Br J Surg. 78:326–330. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hunt TM, Flowerdew AD, Britten AJ, et al:
An association between parameters of liver blood flow and
percentage hepatic replacement with tumour. Br J Cancer.
59:410–414. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Taylor I, Bennett R and Sherriff S: The
blood supply of colorectal liver metastases. Br J Cancer.
38:749–756. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Leen E, Goldberg JA, Robertson J, et al:
Detection of hepatic metastases using duplex/color Doppler
sonography. Ann Surg. 214:599–604. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Leen E, Goldberg JA, Anderson JR, et al:
Hepatic perfusion changes in patients with liver metastases:
comparison with those patients with cirrhosis. Gut. 34:554–557.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Leen E, Goldberg JA, Robertson J, et al:
Early detection of occult colorectal hepatic metastases using
duplex colour Doppler sonography. Br J Surg. 80:1249–1251. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ternberg JL and Butcher HR Jr: Blood-flow
relation between hepatic artery and portal vein. Science.
150:1030–1031. 1965. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mathie RT, Lam PH, Harper AM and Blumgart
LH: The hepatic arterial blood flow response to portal vein
occlusion in the dog: the effect of hepatic denervation. Pflugers
Arch. 386:77–83. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ayuse T, Brienza N, Revelly JP, O’Donnell
CP, Boitnott JK and Robotham JL: Alternations in liver hemodynamics
in an intact porcine model of endotoxin shock. Am J Physiol.
268:H1106–H1114. 1995.PubMed/NCBI
|
|
43
|
Rocheleau B, Ethier C, Houle R, Huet PM
and Bilodeau M: Hepatic artery buffer response following left
portal vein ligation: its role in liver tissue homeostasis. Am J
Physiol. 277:G1000–G1007. 1999.PubMed/NCBI
|
|
44
|
Henderson JM, Gilmore GT, Mackay GJ,
Galloway JR, Dodson TF and Kutner MH: Hemodynamics during liver
transplantation: the interactions between cardiac output and portal
venous and hepatic arterial flows. Hepatology. 16:715–718. 1992.
View Article : Google Scholar
|
|
45
|
Gülberg V, Haag K, Rössle M and Gerbes AL:
Hepatic arterial buffer response in patients with advanced
cirrhosis. Hepatology. 35:630–634. 2002.PubMed/NCBI
|
|
46
|
Gülberg V and Schoenberg SO: Hepatic
arterial buffer response: visualization by multiphasic
high-resolution 3D magnetic resonance angiography. J Hepatol.
40:1812004.PubMed/NCBI
|
|
47
|
Mücke I, Richter S, Menger MD and Vollmar
B: Significance of hepatic arterial responsiveness for adequate
tissue oxygenation upon portal vein occlusion in cirrhotic livers.
Int J Colorectal Dis. 15:335–341. 2000.PubMed/NCBI
|
|
48
|
Richter S, Mücke I, Menger MD and Vollmar
B: Impact of intrinsic blood flow regulation in cirrhosis:
maintenance of hepatic arterial buffer response. Am J Physiol
Gastrointest Liver Physiol. 279:G454–G462. 2000.PubMed/NCBI
|
